Cargando…

Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression

BACKGROUND: Tumor recurrence and pseudoprogression (PsP) have similar imaging manifestations in conventional magnetic resonance imaging (MRI), although the subsequent treatments are completely different. This study aimed to evaluate the value of perfusion-weighted imaging (PWI) in differentiating Ps...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jun, Wang, Yulin, Wang, Yan, Xiao, Huafeng, Chen, Xinjing, Lei, Yifei, Feng, Zhebin, Ma, Xiaodong, Ma, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511424/
https://www.ncbi.nlm.nih.gov/pubmed/36185045
http://dx.doi.org/10.21037/qims-22-32
_version_ 1784797639241367552
author Zhang, Jun
Wang, Yulin
Wang, Yan
Xiao, Huafeng
Chen, Xinjing
Lei, Yifei
Feng, Zhebin
Ma, Xiaodong
Ma, Lin
author_facet Zhang, Jun
Wang, Yulin
Wang, Yan
Xiao, Huafeng
Chen, Xinjing
Lei, Yifei
Feng, Zhebin
Ma, Xiaodong
Ma, Lin
author_sort Zhang, Jun
collection PubMed
description BACKGROUND: Tumor recurrence and pseudoprogression (PsP) have similar imaging manifestations in conventional magnetic resonance imaging (MRI), although the subsequent treatments are completely different. This study aimed to evaluate the value of perfusion-weighted imaging (PWI) in differentiating PsP from glioma recurrence. METHODS: A comprehensive literature search was performed to evaluate clinical studies focused on differentiating recurrent glioma from PsP using PWI, including dynamic susceptibility contrast MRI (DSC-MRI), dynamic contrast enhanced MRI (DCE-MRI), and arterial spin labeling (ASL). Study selection and data extraction were independently completed by two reviewers. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool was applied to evaluate the quality of the included studies. The software Stata 16.0 and Meta-Disc 1.4 were used for the meta-analysis. Meta-regression and subgroup analyses were applied to identify the sources of heterogeneity in the studies. This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) prior to initiation (CRD42022304404). RESULTS: A total of 40 studies were included, including 27 English studies and 13 Chinese studies. There were 1,341 patients with glioma recurrence and 876 patients with PsP. The pooled sensitivity and specificity of DSC-MRI for differentiating glioma recurrence from PsP were 0.82 [95% confidence interval (CI): 0.78 to 0.86] and 0.87 (95% CI: 0.80 to 0.92), respectively. The pooled sensitivity and specificity of DCE-MRI were 0.83 (95% CI: 0.76 to 0.89) and 0.83 (95% CI: 0.78 to 0.87), respectively. The pooled sensitivity and specificity of ASL were 0.80 (95% CI: 0.73 to 0.86) and 0.86 (95% CI: 0.76 to 0.92), respectively. DISCUSSION: The DSC-MRI, DCE-MRI, and ASL perfusion techniques displayed high accuracy in distinguishing glioma recurrence from PsP, and DSC-MRI had a higher diagnostic performance than the other two techniques. However, due to the diversity of the parameters and threshold differences, further investigation and standardization are needed.
format Online
Article
Text
id pubmed-9511424
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-95114242022-10-01 Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression Zhang, Jun Wang, Yulin Wang, Yan Xiao, Huafeng Chen, Xinjing Lei, Yifei Feng, Zhebin Ma, Xiaodong Ma, Lin Quant Imaging Med Surg Original Article BACKGROUND: Tumor recurrence and pseudoprogression (PsP) have similar imaging manifestations in conventional magnetic resonance imaging (MRI), although the subsequent treatments are completely different. This study aimed to evaluate the value of perfusion-weighted imaging (PWI) in differentiating PsP from glioma recurrence. METHODS: A comprehensive literature search was performed to evaluate clinical studies focused on differentiating recurrent glioma from PsP using PWI, including dynamic susceptibility contrast MRI (DSC-MRI), dynamic contrast enhanced MRI (DCE-MRI), and arterial spin labeling (ASL). Study selection and data extraction were independently completed by two reviewers. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool was applied to evaluate the quality of the included studies. The software Stata 16.0 and Meta-Disc 1.4 were used for the meta-analysis. Meta-regression and subgroup analyses were applied to identify the sources of heterogeneity in the studies. This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) prior to initiation (CRD42022304404). RESULTS: A total of 40 studies were included, including 27 English studies and 13 Chinese studies. There were 1,341 patients with glioma recurrence and 876 patients with PsP. The pooled sensitivity and specificity of DSC-MRI for differentiating glioma recurrence from PsP were 0.82 [95% confidence interval (CI): 0.78 to 0.86] and 0.87 (95% CI: 0.80 to 0.92), respectively. The pooled sensitivity and specificity of DCE-MRI were 0.83 (95% CI: 0.76 to 0.89) and 0.83 (95% CI: 0.78 to 0.87), respectively. The pooled sensitivity and specificity of ASL were 0.80 (95% CI: 0.73 to 0.86) and 0.86 (95% CI: 0.76 to 0.92), respectively. DISCUSSION: The DSC-MRI, DCE-MRI, and ASL perfusion techniques displayed high accuracy in distinguishing glioma recurrence from PsP, and DSC-MRI had a higher diagnostic performance than the other two techniques. However, due to the diversity of the parameters and threshold differences, further investigation and standardization are needed. AME Publishing Company 2022-10 /pmc/articles/PMC9511424/ /pubmed/36185045 http://dx.doi.org/10.21037/qims-22-32 Text en 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zhang, Jun
Wang, Yulin
Wang, Yan
Xiao, Huafeng
Chen, Xinjing
Lei, Yifei
Feng, Zhebin
Ma, Xiaodong
Ma, Lin
Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression
title Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression
title_full Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression
title_fullStr Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression
title_full_unstemmed Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression
title_short Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression
title_sort perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511424/
https://www.ncbi.nlm.nih.gov/pubmed/36185045
http://dx.doi.org/10.21037/qims-22-32
work_keys_str_mv AT zhangjun perfusionmagneticresonanceimaginginthedifferentiationbetweengliomarecurrenceandpseudoprogressionasystematicreviewmetaanalysisandmetaregression
AT wangyulin perfusionmagneticresonanceimaginginthedifferentiationbetweengliomarecurrenceandpseudoprogressionasystematicreviewmetaanalysisandmetaregression
AT wangyan perfusionmagneticresonanceimaginginthedifferentiationbetweengliomarecurrenceandpseudoprogressionasystematicreviewmetaanalysisandmetaregression
AT xiaohuafeng perfusionmagneticresonanceimaginginthedifferentiationbetweengliomarecurrenceandpseudoprogressionasystematicreviewmetaanalysisandmetaregression
AT chenxinjing perfusionmagneticresonanceimaginginthedifferentiationbetweengliomarecurrenceandpseudoprogressionasystematicreviewmetaanalysisandmetaregression
AT leiyifei perfusionmagneticresonanceimaginginthedifferentiationbetweengliomarecurrenceandpseudoprogressionasystematicreviewmetaanalysisandmetaregression
AT fengzhebin perfusionmagneticresonanceimaginginthedifferentiationbetweengliomarecurrenceandpseudoprogressionasystematicreviewmetaanalysisandmetaregression
AT maxiaodong perfusionmagneticresonanceimaginginthedifferentiationbetweengliomarecurrenceandpseudoprogressionasystematicreviewmetaanalysisandmetaregression
AT malin perfusionmagneticresonanceimaginginthedifferentiationbetweengliomarecurrenceandpseudoprogressionasystematicreviewmetaanalysisandmetaregression